Enhanced risk stratification in chronic coronary syndrome using the left atrioventricular coupling index

Ailís Ceara Haney1,2, Janek Salatzki3,4, Yahya Badran3

  • 1Department of Cardiology, Angiology and Pneumology, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany. ailisceara.haney@med.uni-heidelberg.de.

Insights

The left atrioventricular coupling index (LACI) predicts heart failure hospitalizations and all-cause death in chronic coronary syndrome patients. This cardiovascular magnetic resonance imaging metric offers value beyond traditional risk factors.

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Prognostics

Background:

  • Chronic coronary syndrome (CCS) poses significant cardiovascular risk.
  • Predictive markers for adverse outcomes in CCS are crucial for patient management.
  • Cardiovascular magnetic resonance (CMR) offers advanced imaging capabilities for risk stratification.

Purpose of the Study:

  • To evaluate the prognostic significance of the left atrioventricular coupling index (LACI) in patients with CCS.
  • To determine if LACI, measured by CMR, predicts major adverse cardiovascular events (MACE), heart failure hospitalizations (HFH), and all-cause death.
  • To assess the incremental prognostic value of LACI beyond established clinical and imaging parameters.

Main Methods:

  • Retrospective analysis of 613 CCS patients who underwent CMR stress testing (2008-2018).
  • LACI calculated as the ratio of left atrial to left ventricular end-diastolic volume.
  • Primary endpoint: MACE (cardiac death, myocardial infarction). Secondary endpoints: HFH, all-cause death. Global longitudinal strain also assessed.

Main Results:

  • LACI did not significantly predict MACE (HR 1.01, p=0.07).
  • LACI significantly predicted HFH (HR 1.02, p<0.0001) and all-cause death (HR 1.02, p<0.0001).
  • LACI demonstrated incremental prognostic value for HFH, independent of clinical factors and global longitudinal strain.

Conclusions:

  • LACI is a significant predictor of all-cause death and HFH in CCS patients.
  • LACI provides added prognostic information for HFH beyond traditional risk factors and CMR parameters.
  • LACI may enhance risk stratification in patients with chronic coronary syndrome.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
26
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
43
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
81
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
42
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
52
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
69